Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer

NCT03698370 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
PSA Progression
Recurrent Prostate Carcinoma

Interventions

DRUG: Gallium Ga 68 DOTA-NeoBOMB1
DEVICE: Gallium Ga 68 PSMA-R2

Sponsor

Andrei Iagaru